Literature DB >> 7037853

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.

A Schaffner, H Douglas, A Braude.   

Abstract

By comparing natural immunity to Aspergillus fumigatus (AF) in vivo with the action of human or mouse phagocytes against AF in vitro, we delineated two sequential lines of defense against AF. The first line of defense was formed by macrophages and directed against spores. Macrophages prevented germination and killed spores in vitro and rapidly eradicated conidia in vivo, even in neutropenic and athymic mice. The second was the neutrophilic granulocyte (PMN), which protected against the hyphal form of AF. Human and mouse PMN killed mycelia in vitro. Normal, but not neutropenic mice, stopped hyphal growth, and eradicated mycelia. Either line of defense acting alone protected mice from high challenge doses. Natural immunity collapsed only when both the reticuloendothelial system and PMN were impaired. These findings are in keeping with the clinical observation that high doses of cortisone and neutropenia are the main risk factors for invasive aspergillosis. Cortisone inhibited the conidiacidal activity of mouse macrophages in vivo and of human or mouse mononuclear phagocytes in vitro. Cortisone damaged this first line of defense directly and not through the influence of T lymphocytes or other systems modifying macrophage function as shown in athymic mice and in vitro. In addition, daily high doses of cortisone in mice reduced the mobilization of PMN so that the second line of defense was also impaired. Thus, cortisone can break down natural resistance on its own. Myelosuppression rendered mice susceptible only when the first line of defense was overpowered by high challenge doses, by activated spores that cannot be killed by macrophages, or by cortisone suppression of the conidiacidal activity of macrophages. The host, thus, can call upon two independent phagocytic cell lines that form graded defense systems against aspergillus. These lines of defense function in the absence of a specific immune response, which seems superfluous in the control and elimination of this fungus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037853      PMCID: PMC371019          DOI: 10.1172/jci110489

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Device for inhalation exposure of animals to spores.

Authors:  W R PIGGOTT; C W EMMONS
Journal:  Proc Soc Exp Biol Med       Date:  1960-04

2.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

3.  Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B.

Authors:  J R Burton; J B Zachery; R Bessin; H K Rathbun; W B Greenough; S Sterioff; J R Wright; R E Slavin; G M Williams
Journal:  Ann Intern Med       Date:  1972-09       Impact factor: 25.391

4.  Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients.

Authors:  M C Bach; J L Adler; J Breman; F K P'eng; A Sahyoun; R M Schlesinger; P Madras; A P Monaco
Journal:  Lancet       Date:  1973-01-27       Impact factor: 79.321

5.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

6.  Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis.

Authors:  R D Diamond; R Krzesicki; B Epstein; W Jao
Journal:  Am J Pathol       Date:  1978-05       Impact factor: 4.307

7.  Experimental visceral aspergillosis.

Authors:  H Sidransky; S M Epstein; E Verney; C Horowitz
Journal:  Am J Pathol       Date:  1972-10       Impact factor: 4.307

8.  Experimental mycosis in immunosuppressed rabbits. II. Acute and chronic aspergillosis.

Authors:  J W Rippon; D N Anderson
Journal:  Mycopathologia       Date:  1978-10-16       Impact factor: 2.574

9.  Experimental study of the pathogenicity of aspergilli for mice.

Authors:  S Ford; L Friedman
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

10.  Effects of corticosteroids on human monocyte function.

Authors:  J J Rinehart; S P Balcerzak; A L Sagone; A F LoBuglio
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  172 in total

1.  Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae.

Authors:  J E Wang; A Warris; E A Ellingsen; P F Jørgensen; T H Flo; T Espevik; R Solberg; P E Verweij; A O Aasen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Intubation practice on cadavers should stop.

Authors:  Alison Tonks
Journal:  BMJ       Date:  1992-08-08

Review 3.  Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.

Authors:  Rami Sherif; Brahm H Segal
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

4.  Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.

Authors:  Viviane Balloy; Mustapha Si-Tahar; Osamu Takeuchi; Bruno Philippe; Marie-Anne Nahori; Myriam Tanguy; Michel Huerre; Shizuo Akira; Jean-Paul Latgé; Michel Chignard
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection.

Authors:  G P Bodey; E Anaissie; J Gutterman; S Vadhan-Raj
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

6.  Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis.

Authors:  J M Smith; C M Tang; S Van Noorden; D W Holden
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.

Authors:  E Roilides; K Uhlig; D Venzon; P A Pizzo; T J Walsh
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Role of neutrophils in preventing and resolving acute fungal sinusitis.

Authors:  Tobias E Rodriguez; Nicole R Falkowski; Jack R Harkema; Gary B Huffnagle
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

9.  Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

Authors:  R Amitani; G Taylor; E N Elezis; C Llewellyn-Jones; J Mitchell; F Kuze; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Silencing of mitochondrial alternative oxidase gene of Aspergillus fumigatus enhances reactive oxygen species production and killing of the fungus by macrophages.

Authors:  Taisa Magnani; Frederico Marianetti Soriani; Vicente de Paulo Martins; Anna Carolina de Freitas Policarpo; Carlos Artério Sorgi; Lúcia Helena Faccioli; Carlos Curti; Sérgio Akira Uyemura
Journal:  J Bioenerg Biomembr       Date:  2009-01-16       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.